What is considered frontline therapy for Thromboangiitis Obliterans?

• A. Aspirin
• B. Amlodipine
• C. Exercise
• D. Tobacco cessation

Answer: (D)

The key idea is that stopping tobacco use is the cornerstone of treatment for Thromboangiitis Obliterans. This disease is tightly linked to tobacco exposure and causes inflammatory thrombosis of small and medium arteries and veins in the extremities. Ongoing tobacco use sustains endothelial injury and occlusion, so continuing to smoke drives progression and tissue ischemia. When a patient quits tobacco, the inflammatory process often slows or stops, and symptoms can improve, making cessation the only disease-modifying step.

Other measures may help tem porarily with symptoms but do not alter the course of the disease. For example, aspirin or other antiplatelet therapies don’t address the underlying vasculitis, and vasodilators like amlodipine may relieve vasospasm but don’t halt progression. Exercise can improve limb perfusion and claudication in peripheral arterial disease in general, but it’s not the primary intervention that changes the disease trajectory in Thromboangiitis Obliterans.